GB2182949B - Monoclonal antibodies and antigens for human non-small cell lung carcinomas - Google Patents

Monoclonal antibodies and antigens for human non-small cell lung carcinomas

Info

Publication number
GB2182949B
GB2182949B GB8616219A GB8616219A GB2182949B GB 2182949 B GB2182949 B GB 2182949B GB 8616219 A GB8616219 A GB 8616219A GB 8616219 A GB8616219 A GB 8616219A GB 2182949 B GB2182949 B GB 2182949B
Authority
GB
United Kingdom
Prior art keywords
small cell
cell lung
residues
antigens
human non
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8616219A
Other languages
English (en)
Other versions
GB8616219D0 (en
GB2182949A (en
Inventor
Ingegerd Hellstrom
Joseph Patrick Brown
Karl Erik Hellstrom
Diane Horn
Peter Linsley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of GB8616219D0 publication Critical patent/GB8616219D0/en
Publication of GB2182949A publication Critical patent/GB2182949A/en
Application granted granted Critical
Publication of GB2182949B publication Critical patent/GB2182949B/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB8616219A 1984-11-02 1985-10-30 Monoclonal antibodies and antigens for human non-small cell lung carcinomas Expired GB2182949B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66752184A 1984-11-02 1984-11-02
US78517785A 1985-10-07 1985-10-07

Publications (3)

Publication Number Publication Date
GB8616219D0 GB8616219D0 (en) 1986-08-13
GB2182949A GB2182949A (en) 1987-05-28
GB2182949B true GB2182949B (en) 1989-05-24

Family

ID=27099700

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8616219A Expired GB2182949B (en) 1984-11-02 1985-10-30 Monoclonal antibodies and antigens for human non-small cell lung carcinomas

Country Status (21)

Country Link
EP (2) EP0566066A1 (https=)
JP (3) JPH0675514B2 (https=)
KR (1) KR910000903B1 (https=)
AT (1) ATE117089T1 (https=)
AU (1) AU599578B2 (https=)
DE (1) DE3587976T2 (https=)
DK (1) DK170619B1 (https=)
ES (1) ES8704735A1 (https=)
FI (1) FI85814C (https=)
GB (1) GB2182949B (https=)
GR (1) GR852622B (https=)
HU (1) HU208546B (https=)
IE (1) IE58590B1 (https=)
IL (1) IL76877A (https=)
NO (1) NO862690D0 (https=)
NZ (1) NZ214055A (https=)
OA (1) OA08354A (https=)
PH (1) PH24961A (https=)
PT (1) PT81418B (https=)
WO (1) WO1986002735A1 (https=)
YU (1) YU46386B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708930A (en) * 1984-11-09 1987-11-24 Coulter Corporation Monoclonal antibody to a human carcinoma tumor associated antigen
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途
AU601680B2 (en) * 1985-05-28 1990-09-20 Joseph P. Brown Monoclonal antibodies for human non-small cell lung carcinomas
US5185432A (en) * 1986-02-26 1993-02-09 Oncogen Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
JPS6319561A (ja) * 1986-07-11 1988-01-27 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
IL89102A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Vectors,compounds and methods for expression of a human adenocarcinoma antigen
AU632469B2 (en) * 1988-04-04 1993-01-07 Johns Hopkins University, The A method for early detection of lung cancer
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
IT1264490B (it) * 1992-02-17 1996-09-24 Uni Degli Studi G D Annunzio C Antigene 90k associato a tumori.
JPH0727604U (ja) * 1993-06-18 1995-05-23 修司 坂本 磁気治療具
EP0695760A1 (en) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Novel tumor marker for lung cancer
DE202012001863U1 (de) 2012-02-22 2012-03-19 Haldex Brake Products Ab Scheibenbremse und Sensoreinrichtung hierfür

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途
AU601680B2 (en) * 1985-05-28 1990-09-20 Joseph P. Brown Monoclonal antibodies for human non-small cell lung carcinomas

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Arch. Bioche *
Can. Res. (1 *
Fed. Proc. ( *
Hybridoma (1 *
In Vitro (19 *
Int. J. Can. *
J. Immun. (1 *
Proc. Nat.Ac *
Semin. Oncol *

Also Published As

Publication number Publication date
JPH06340699A (ja) 1994-12-13
DE3587976T2 (de) 1995-05-18
JPH0733400B2 (ja) 1995-04-12
JPH0675514B2 (ja) 1994-09-28
IL76877A (en) 1991-11-21
FI85814B (fi) 1992-02-28
EP0207090A4 (en) 1988-04-26
FI862821A0 (fi) 1986-07-02
AU599578B2 (en) 1990-07-26
YU46386B (sh) 1993-10-20
IE852681L (en) 1986-05-02
JPH06296497A (ja) 1994-10-25
JPS62501955A (ja) 1987-08-06
GR852622B (https=) 1986-03-04
HU208546B (en) 1993-11-29
ES548421A0 (es) 1987-04-16
DE3587976D1 (de) 1995-02-23
IE58590B1 (en) 1993-10-20
GB8616219D0 (en) 1986-08-13
DK314586A (da) 1986-09-01
JP2567564B2 (ja) 1996-12-25
EP0207090A1 (en) 1987-01-07
FI862821L (fi) 1986-07-02
NZ214055A (en) 1991-06-25
FI85814C (fi) 1992-06-10
GB2182949A (en) 1987-05-28
PT81418B (pt) 1987-11-11
HUT43188A (en) 1987-09-28
YU172185A (en) 1989-08-31
EP0566066A1 (en) 1993-10-20
NO862690D0 (no) 1986-07-02
KR910000903B1 (ko) 1991-02-12
IL76877A0 (en) 1986-02-28
AU5069185A (en) 1986-05-15
DK170619B1 (da) 1995-11-13
WO1986002735A1 (en) 1986-05-09
EP0207090B1 (en) 1995-01-11
DK314586D0 (da) 1986-07-02
ES8704735A1 (es) 1987-04-16
KR880700268A (ko) 1988-02-22
PH24961A (en) 1990-12-26
ATE117089T1 (de) 1995-01-15
OA08354A (en) 1988-02-29
PT81418A (en) 1985-11-01

Similar Documents

Publication Publication Date Title
GB2182949B (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
Fullmer et al. Bovine intestinal calcium-binding proteins: Purification and some properties
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
Jander et al. A collagen-like glycoprotein of the extracellular matrix is the undegraded form of type VI collagen
BR9500732A (pt) Peptídio imunologicamente ativo,fragmento de DNA isolado,kit de teste e aplicação
GR861141B (en) Particles having the immunogenic properties of the hbs antigen and an antigenic side strange to the epitopes of the antigen hbs vectors and animals cells for the production of said particles and compositions containing such particles
KR950704489A (ko) 인터페론 타우 조성물 및 사용방법(interferon tau compositions and methods of use)
KR100215606B1 (en) Toxoplasma gondii antigens, the preparation thereof and the diagnostic agent containing them
WO1997012044A3 (en) Pichia secretory leader for protein expression
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
GR3007909T3 (https=)
AUPM772494A0 (en) Improvements in production of proteins in host cells
Carding et al. Multiple proteins related to the soluble galactose-binding animal lectin revealed by a monoclonal anti-lectin antibody
Banga et al. Comparative biochemical analysis of purified S-antigen from human, bovine, porcine and rat retina
EP0206849A3 (en) Method for the diagnosis in vitro of malignant cells originating from the digestive duct
EP0750040A3 (en) Macrophage stimulating protein variant and method for producing the same
Schalekamp et al. Recombination of embryonic haemoglobin chains during the development of the chick
Alekseeva et al. Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues.
Strnad et al. Biochemical characterization of Epstein-Barr virus membrane antigen associated glycoproteins
Mohr et al. Antibodies to interleukin-2 (IL-2) in patients: cross reactivity with different IL-2 species
Karkhanis et al. Antigenic subunit of the polypeptide antigenic complex of the Melvin strain of Neisseria gonorrhoeae

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19981030